Dysphagia for Solids — Approach & Management

"Historical points suggestive of a motor disorder are difficulty with both solids and liquids, as opposed to only with solids, which is more suggestive of mechanical obstruction."

Step 1 — Diagnosis First

Initial investigation sequence:

Step 2 — Cause-Directed Management

A. Benign Stricture (peptic, post-radiation, anastomotic)

• Endoscopic dilation (bougie or water-filled balloon) — first-line
• If stricture is from radiotherapy: dilate with extra caution (higher perforation risk)
• If stricture is caused by reflux esophagitis: treat with a PPI first — dysphagia may resolve without dilation once esophagitis heals

B. Schatzki Ring (lower esophageal mucosal ring)

• Presents with intermittent solid food dysphagia; symptoms don't occur until ring diameter < 13 mm
• Pathophysiology: mucosal ring just above the GEJ; possibly related to GERD
• Treatment: endoscopic dilation
• Acid suppression (PPI) may be adjunctive given GERD association — KJ Lee's Essential Otolaryngology

C. Eosinophilic Esophagitis (EoE)

• Can appear endoscopically subtle; biopsies are mandatory even with a normal-looking esophagus
• Treatment: PPI trial, swallowed topical corticosteroids (fluticasone/budesonide), dietary elimination, endoscopic dilation for refractory strictures

D. Esophageal Carcinoma

• Progressive dysphagia for solids is the hallmark presentation
• Endoscopic biopsy is the primary diagnostic step
• Management depends on tumor stage, location, presence of metastases, and patient performance status

E. Achalasia (atypical presentation — solids + liquids usual, but early disease may be solids-only)

• If manometry confirms achalasia:
  • Endoscopic pneumatic dilation
  • Botulinum toxin injection to LES (less durable)
  • Heller myotomy ± fundoplication — 70–90% success rate
  • Per-oral endoscopic myotomy (POEM)

F. Spastic Motor Disorders (Diffuse Esophageal Spasm / Jackhammer Esophagus)

• First-line: calcium channel blockers (nifedipine) or nitric oxide donors (nitroglycerin)
• Side-effects often limit these agents
• Botulinum toxin injections as alternative

G. Absent Contractility (e.g., Systemic Sclerosis / Scleroderma)

• Therapeutic options are limited
• Dietary and lifestyle modification (favor liquids and semisolids over solids; small frequent meals)
• Aggressive acid suppression (PPI) — critical as reflux worsens stricturing

H. Zenker Diverticulum

• Symptoms: dysphagia + regurgitation + halitosis ± gurgling after eating
• Treatment: endoscopic cricopharyngeal myotomy (flexible or rigid) or open surgical repair

I. Vascular Compression (Arteria Lusoria, Thoracic Aortic Aneurysm)

• Rare; the only effective treatment is vascular surgery

Step 3 — If Endoscopy and Manometry Are Both Unrevealing

• Obtain biopsies to exclude EoE
• Proceed to barium swallow for dynamic structural assessment
• Consider functional lumen imaging probe (FLIP) as an adjunct if available

Summary Algorithm

Dysphagia for SOLIDS only
        ↓
  Upper endoscopy + biopsies
        ↓
  ┌─────────────────────────────────────────┐
  │ Structural found?                        │
  │  • Stricture → dilation ± PPI           │
  │  • Schatzki ring → dilation ± PPI       │
  │  • EoE → topical steroids / diet / PPI  │
  │  • Tumor → staging + oncology           │
  └─────────────────────────────────────────┘
        ↓ No structural cause
  Barium swallow → Esophageal manometry
        ↓
  ┌──────────────────────────────────────────┐
  │ Motility disorder found?                  │
  │  • Achalasia → dilation/myotomy/POEM     │
  │  • DES/Jackhammer → CCB, nitrates, Botox │
  │  • Absent contractility → diet + PPI     │
  └──────────────────────────────────────────┘

Treatment of Dysphagia for Solids (Mechanical Causes)

1. Schatzki Ring (B Ring)

"Symptomatic rings that are refractory to dilation have been successfully treated by endoscopic means using electrocautery incision." — Sleisenger & Fordtran's

2. Peptic / Benign Stricture

3. Eosinophilic Esophagitis (EoE)

A. Dietary

• Empiric 6-food elimination diet: remove cow's milk (casein), soy, wheat, eggs, peanuts/tree nuts, seafood
• Can be stepped down: 1-, 2-, or 4-food elimination depending on response
• Elemental diet for severe/refractory disease
• Formal allergy evaluation only if accompanying atopic disease

B. Pharmacological

Relapse occurs in up to 95% of patients when treatment is stopped — chronic/maintenance therapy is typically required.

C. Endoscopic

• Dilation for strictures or narrow-caliber esophagus — used when food impaction or significant luminal narrowing is present; does not treat underlying eosinophilic inflammation

4. Esophageal Carcinoma

• Management depends on stage, location, metastatic status, and performance status
• Involves oncology, surgery, radiation oncology
• Endoscopic palliation (stenting, dilation) for unresectable disease

5. Achalasia (if found on workup)

6. Spastic Disorders (DES / Jackhammer Esophagus)

7. Scleroderma / Absent Contractility

• No disease-modifying esophageal treatment available
• Aggressive PPI — critical; severe reflux causes stricturing
• Dietary modification: small frequent meals, liquid/semisolid consistency preference
• Upright posture for at least 2 hours post-meal

Quick Reference by Cause

Role of Muscarinic Agonists in Dysphagia

The Short Answer: Limited and Largely Obsolete

Bethanechol — Mechanism & GI Effects

• Enhances amplitude of contractions throughout the GI tract
• Increases resting lower esophageal sphincter (LES) pressure
• Does NOT coordinate contractions — gastric emptying and small bowel transit are not necessarily accelerated

"Bethanechol is not a true prokinetic agent." — Yamada's Textbook of Gastroenterology

Historical Role in Dysphagia / GERD

• Proton pump inhibitors (PPIs) are now the standard — they are far more effective at controlling reflux and far better tolerated
• Bethanechol has been replaced by PPIs for this indication — Katzung's Basic & Clinical Pharmacology, 16th ed.

Why Muscarinic Agonists Are Not Used for Dysphagia for Solids

• The problem is structural narrowing, not failure of muscular contraction
• Increasing muscular contraction amplitude will not relieve luminal obstruction
• Bethanechol cannot dilate a ring or dissolve a stricture

• Achalasia involves failure of LES relaxation — a muscarinic agonist that increases LES pressure would worsen the obstruction
• DES involves uncoordinated high-amplitude contractions — a drug that enhances contractions would also be counterproductive

Important Caution

"The clinician must be certain there is no mechanical obstruction before using a cholinomimetic. Otherwise, the drug may exacerbate the problem and possibly cause perforation as a result of increased intraluminal pressure." — Katzung's Basic & Clinical Pharmacology

Where Muscarinic Agonists Do Have a Role (GI, but not dysphagia)

Bottom Line